A comparison of cabergoline and bromocriptine on the risk of valvular heart disease in patients with prolactinomas

Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and doppler echocardiography

William A. Zoghbi, Maurice Enriquez‐Sarano, Elyse Foster et al. · Journal of the American Society of Echocardiography · 2003 · 4K citations · Full text

Heart Failure, Radiology, Doppler Echocardiography +8

Prevalence and clinical determinants of mitral, tricuspid, and aortic regurgitation (the Framingham Heart Study)

Jagmeet Singh, Jane C. Evans, Daniel Levy et al. · The American Journal of Cardiology · 1999 · 1.3K citations · Full text

Valvular Heart Disease and the Use of Dopamine Agonists for Parkinson's Disease

R Zanettini, Angelo Antonini, Gemma Gatto et al. · New England Journal of Medicine · 2007 · 874 citations · Full text

Guidelines of the Pituitary Society for the diagnosis and management of prolactinomas

Felipe F. Casanueva, Mark E. Molitch, Janet Schlechte et al. · Clinical Endocrinology · 2006 · 822 citations · Full text

Dopamine Agonists and the Risk of Cardiac-Valve Regurgitation

R Schade, Frank Andersohn, Samy Suissa et al. · New England Journal of Medicine · 2007 · 708 citations